YIH
KNTE

Y-Intercept (HK)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Y-Intercept (HK)’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,410
Closed -$43.6K – 1847
2023
Q4 		$43.6K Buy
+18,410
New +$43.6K ﹤0.01% 1168
2023
Q3 		– Sell
-33,702
Closed -$102K – 1753
2023
Q2 		$102K Buy
+33,702
New +$102K 0.01% 1094